Phmurph, I'm suggesting they license Cavatak for one of the cancer types (eg. bladder) at $200m. Imagine the return on separate licences for (how many cancer types are there again?)
But this is just my daydream. No one else has to buy into it!
- Forums
- ASX - By Stock
- Broker upgrade
Phmurph, I'm suggesting they license Cavatak for one of the...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)